carteolol and penbutolol

carteolol has been researched along with penbutolol in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Covey, S; Frishman, WH	1

Reviews

1 review(s) available for carteolol and penbutolol

Article	Year
Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism. Journal of clinical pharmacology, 1990, Volume: 30, Issue:5 Topics: Arrhythmias, Cardiac; Carteolol; Chemical Phenomena; Chemistry; Coronary Disease; Humans; Hypertension; Penbutolol; Propanolamines	1990

Trials

1 trial(s) available for carteolol and penbutolol

Article	Year
Carteolol and penbutolol for hypertension. The Medical letter on drugs and therapeutics, 1989, Jul-28, Volume: 31, Issue:797 Topics: Adrenergic beta-Agonists; Carteolol; Clinical Trials as Topic; Humans; Hypertension; Penbutolol; Propanolamines	1989

Other Studies

2 other study(ies) available for carteolol and penbutolol

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004

Article

Year

QSAR model for drug human oral bioavailability.

Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004